MADISON LAWRENCE: Open Payments
NPI 1154043057 · HANOVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 25 payments from 14 companies in 2025. Trend: 2023 $262 · 2024 $1,184 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $62 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Lilly USA, LLC | 3 | $55 |
| ABBVIE INC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Novo Nordisk Inc | 2 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: The Cologuard Plus Collection Kit, QULIPTA, SHINGRIX, MOUNJARO, ELIQUIS, REXULTI, Ozempic, Kerendia.
Industry payments across PA — which companies pay providers there.
